ENDONOVO THERAPEUTICS, INC. Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months
ENDONOVO THERAPEUTICS, INC. (ENDV) had Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months of $646.91 thousand as of 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths · last filed 2018-08-13
- 2018-06-30: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $646.91K.
- 2018-03-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $646.91K.
- 2017-12-31: Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months $646.91K.
| Period end | Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months |
|---|---|
| 2018-06-30 | $646.91K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $646.91K 10-Q · filed 2018-05-18 |
| 2017-12-31 | $646.91K 10-K · filed 2018-04-06 |